(Z)-2-(2-Aminothiazole-4-yl-)-2-trityloxyimino acetic acid | CAS:128438-01-7

We serve (Z)-2-(2-Aminothiazole-4-yl-)-2-trityloxyimino acetic acid CAS:128438-01-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
(Z)-2-(2-Aminothiazole-4-yl-)-2-trityloxyimino acetic acid

Chemical Name:(Z)-2-(2-Aminothiazole-4-yl-)-2-trityloxyimino acetic acid
CAS.NO:128438-01-7
Synonyms:(2Z)-(2-amino-1,3-thiazol-4-yl)[(trityloxy)imino]ethanoic acid
ATOA
AT-TOA
Molecular Formula:C24H19N3O3S
Molecular Weight:429.49100
 
Physical and Chemical Properties:
Density:1.295
Boiling point:651.477ºC
Flash point:347.801ºC
Index of Refraction:1.66
 
Specification:
Appearance:White powder
Purity:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:For the synthesis of cefdinir



Contact us for information like (Z)-2-(2-Aminothiazole-4-yl-)-2-trityloxyimino acetic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,AT-TOA physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(Z)-2-(2-Aminothiazole-4-yl-)-2-trityloxyimino acetic acid Use and application,(2Z)-(2-amino-1,3-thiazol-4-yl)[(trityloxy)imino]ethanoic acid technical grade,usp/ep/jp grade.


Related News: At Day 35 following administration, a bone marrow assessment showed that FT819 persisted and continued to demonstrate tumor clearance, whereas primary CAR T cells, while persisting, were not able to control tumor growth.1-ethyl-4-(4-iodophenyl)benzene manufacturer At Day 35 following administration, a bone marrow assessment showed that FT819 persisted and continued to demonstrate tumor clearance, whereas primary CAR T cells, while persisting, were not able to control tumor growth.4-Hydroxybenzamide supplier Taiwan previously participated as an observer at the World Health Assembly, the W.H.O.’s governing body.4-Chloro-7-methoxy-2-phenylquinoline vendor With the advancement of supply-side structural reforms, the production of bulk APIs in China will become more concentrated, and the technology will be further improved.A GSK spokesman said it was not yet clear by when ViiV would be able to address the FDA’s concerns.